About Suisse Life Science
Suisse Life Science is a company based in London (United Kingdom) founded in 2014 by Omar Fogliadini was acquired by LIFEdata in April 2018. Suisse Life Science has raised $20 million across 1 funding round from investors including Corundum Neuroscience and LIFEdata.
- Headquarter London, United Kingdom
- Founders Omar Fogliadini
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
-$18.64 K (USD)99as on Dec 31, 2018
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series B
Jun 24, 2018
-
Investors
Corundum Neuroscience
& 1 more
-
Employee Count
Not available
-
Acquired by
LIFEdata
(Apr 01, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Suisse Life Science
Suisse Life Science has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Suisse Life Science
Suisse Life Science has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Corundum Neuroscience and LIFEdata.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Support is provided for neuroscience research and venture building.
|
Locked | Locked | Locked | |
|
Offers AI and data strategies for WhatsApp-based omnichannel operations in retail and B2B.
|
Locked | Locked | Locked |
Investor details for Suisse Life Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Suisse Life Science
Investment portfolio details for Suisse Life Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Suisse Life Science
Detailed financials for Suisse Life Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Suisse Life Science Comparisons
Peer comparison for Suisse Life Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Suisse Life Science
Detailed competitors of Suisse Life Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Suisse Life Science
Complete news archive for Suisse Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suisse Life Science
Suisse Life Science was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Suisse Life Science is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Omar Fogliadini is the current CEO of Suisse Life Science. They have also founded this company.
Suisse Life Science is a funded company, having raised a total of $20M across 1 funding round to date.
Suisse Life Science is a genomics company that has developed a direct to consumer, turnkey platform for genomics-driven proactive healthcare and wellness. The companys platform iDDNA, allows the formulation of specific products, lifestyle interventions, and recommendations based on the customers genetic profile.
Suisse Life Science has 2 investors. Key investors include Corundum Neuroscience, and LIFEdata.